Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

Etoposide 3 fludarabine phosphate 2 fludarabine 2 Cyclophosphamide 2 Carboplatin 2 repotrectinib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 Vorinostat 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Practice Guidelines as Topic 1 Platinum 1 Paclitaxel 1 Nivolumab 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Ifosfamide 1 Cytapheresis 1 Cisplatin 1 Bleomycin 1 Biopsy 1 Automobiles 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Cytapheresis × 90 days × Clear all

NCT00864318 2026-04-14

TICE

Institut Claudius Regaud

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡